ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 117 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,315,000 | -87.0% | 128,300 | -79.0% | 0.18% | -83.4% |
Q3 2018 | $10,150,000 | -38.2% | 609,612 | -41.3% | 1.08% | -41.3% |
Q2 2018 | $16,415,000 | +49.7% | 1,038,900 | +20.3% | 1.84% | +52.5% |
Q1 2018 | $10,968,000 | -26.1% | 863,600 | +21.1% | 1.20% | -30.5% |
Q1 2017 | $14,833,000 | +6.5% | 713,119 | +6.5% | 1.73% | +12.3% |
Q4 2016 | $13,923,000 | -20.9% | 669,351 | +24.6% | 1.54% | -10.8% |
Q3 2016 | $17,601,000 | +34.2% | 537,121 | +2.3% | 1.73% | +27.6% |
Q2 2016 | $13,115,000 | -58.5% | 525,221 | -59.3% | 1.35% | -11.4% |
Q1 2016 | $31,620,000 | +2.4% | 1,291,153 | +38.1% | 1.53% | +16.1% |
Q4 2015 | $30,881,000 | +23.6% | 934,951 | +22.6% | 1.32% | +15.0% |
Q3 2015 | $24,985,000 | -30.9% | 762,682 | +11.7% | 1.14% | -24.1% |
Q2 2015 | $36,165,000 | +16.8% | 682,736 | -36.3% | 1.51% | +28.3% |
Q1 2015 | $30,951,000 | +920.1% | 1,072,437 | +928.2% | 1.18% | +764.0% |
Q4 2014 | $3,034,000 | +168.0% | 104,300 | +16.8% | 0.14% | +183.3% |
Q3 2014 | $1,132,000 | +39.2% | 89,300 | +120.4% | 0.05% | +41.2% |
Q2 2014 | $813,000 | – | 40,525 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |